BIM
RIGL icon

BlackRock Investment Management’s Rigel Pharmaceuticals RIGL Stock Holding History

BlackRock Investment Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$891K Sell
37,438
-64
-0.2% -$1.83K ﹤0.01% 2758
2016
Q3 		$1.38M Buy
37,502
+2,830
+8% +$81.1K ﹤0.01% 2456
2016
Q2 		$773K Buy
34,672
+3,021
+10% +$75.1K ﹤0.01% 2815
2016
Q1 		$658K Sell
31,651
-360
-1% -$8.88K ﹤0.01% 2761
2015
Q4 		$970K Buy
32,011
+320
+1% +$9.7K ﹤0.01% 2623
2015
Q3 		$783K Sell
31,691
-670
-2% -$20K ﹤0.01% 2782
2015
Q2 		$1.04M Buy
32,361
+3,487
+12% +$133K ﹤0.01% 2734
2015
Q1 		$1.03M Sell
28,874
-152
-0.5% -$4.17K ﹤0.01% 2502
2014
Q4 		$659K Sell
29,026
-6,837
-19% -$138K ﹤0.01% 2833
2014
Q3 		$696K Sell
35,863
-293
-0.8% -$8.28K ﹤0.01% 2773
2014
Q2 		$1.31M Buy
36,156
+6,448
+22% +$219K ﹤0.01% 2404
2014
Q1 		$1.15M Sell
29,708
-126
-0.4% -$4.49K ﹤0.01% 2413
2013
Q4 		$850K Sell
29,834
-586
-2% -$17.2K ﹤0.01% 2611
2013
Q3 		$1.09M Buy
30,420
+220
+0.7% +$8.03K ﹤0.01% 2382
2013
Q2 		$1.01M Buy
+30,200
New +$1.37M ﹤0.01% 2344

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock Investment Management's RIGL Position: Q4 2016 in Review

BlackRock Investment Management reduced its Rigel Pharmaceuticals (RIGL) stake by 0.17% in Q4 2016, selling an estimated $1.83K and leaving 37,438 shares worth $891K. The position accounts for ﹤0.01% of the portfolio, ranked #2758.

BlackRock Investment Management first reported a position in RIGL in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.38M in Q3 2016. 107 funds tracked by Wall St. Rank hold RIGL as of Q4 2016.

  • BlackRock Investment Management held 37,438 shares of Rigel Pharmaceuticals worth $891K as of Q4 2016.
  • BlackRock Investment Management sold 64 Rigel Pharmaceuticals shares in Q4 2016, an estimated $1.83K.
  • Rigel Pharmaceuticals made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2758 holding.
  • BlackRock Investment Management first reported a position in Rigel Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Rigel Pharmaceuticals position peaked at $1.38M in Q3 2016.
  • 107 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.